You're watching...
Alan Shortall, CEO and founder of Unilife, on how his company brought its manufacturing back to the U.S.
Also in this playlist...
Auto-advance: ON
Auto-advance
This transcript is automatically generated
A new trend is on the way bringing jobs back.
To the united states of my next -- company was.
Head of -- joining me now is Alan shall awful founder and CEO of -- -- life and Alan thank you for being here.
Really interesting story let's get right to it you had an operation in China the began back -- what 20042005.
This session we we issued an Australian company and we at saw some affection to China.
-- -- -- -- -- -- -- -- -- It is likely that we we -- she design and not a factor in event of injectable drug delivery systems we happen to have a range.
Of safety syringes but our portfolios probably one of the broadest.
In the world in terms of injectable to the -- system.
So why did you come back to the US and number reasons.
And and relates not only to the view this -- an wonderful reputation for high quality medical devices.
And the reason for that is because of the regulations in the US they are so stringent.
Now I know we -- complain that regulations but this is one time when we actually embrace them.
Because it makes us better.
And consequently we can set -- product anywhere in the world because there recognize -- -- for credibility absolutely yes.
So what does this mean for the workforce are you hiring a -- where you based.
Absolutely were based in central Pennsylvania -- we recognize in 2006 or so that.
That transition from a technology development company -- -- company was a big step that many companies failed.
No we did was -- we acquired a company in central Pennsylvania in 2007.
And we relocated -- amount affection China and moved all right -- affection to central Pennsylvania a lot of companies go to China for a cheaper.
Cut down on cost some manufacturing was that the case for you.
Not really -- -- it traction for us was.
That the pharmaceutical customers that we set our devices because too because what pharmaceutical these -- they put the drugs and our device and I deliver the drugs into the market and that.
It's critical for them that they know they're dealing with the best quality that they can possibly get.
They know when we're compliant which we are in -- say it's the best they can get so we move for that but also.
We we recognize that this is a major global opportunity.
We need to be on a global exchange the biggest capital market exchanges are here in the USA so we listed on NASDAQ and gives access to capital to grow the company.
Are you concerned under Obama -- is as slow as far as I can see there's going to be a tax on medical devices that would kicking on January the first is that right -- twenty billion owed taxes or something -- hospital was in one shape or form the going to get us there doesn't make you less competitive no not at all in fact we actually in some ways.
We so actually supply components of the device to the pharmaceutical company so they can put the drugs in them.
I don't ever so -- we don't get given that takes the top of the tax in a lot of our devices but still don't like -- nobody likes tax me.
Very -- congratulations coming back and to this.
Country we appreciate say your information is -- -- challenge Oracle you know -- founder and CEO -- but if -- sit and think very good.
